Please login or register to print this page.

Articles

Browse all our past news

July 22, 2010

CLARITY-AF Study Underway

Enrolement is Underway in the CLARITY-AF Study which compares Efficacy, safety and efficiency of two catheter ablation technologies.

read more

July 22, 2010

RCP Mersey Revalidation Appraisal Pilot Completed

The RCP piloted the GMC Appraisal Framework in secondary care in the Mersey region on behalf of the Revalidation Support Team (RST) and the report was presented recently to the UK Programme Board.

read more

July 22, 2010

RCP backs DH White Paper

“‘The plans set out in the White Paper, (‘Liberating the NHS’) represent a welcome shift towards a greater focus on measuring health services on grounds of quality and outcomes rather than on activity and process targets” said Professor Sir Ian Gilmore, President of the Royal College of Physicians (RCP).

read more

June 25, 2010

Atrial fibrillation, and hypertension

“Hypertension is the most prevalent risk factor leading to the development of atrial fibrillation (AF), the most common arrhythmia” according to Dr I Grundvold, University of Oslo.

read more

June 25, 2010

“NICE” population approach, a model for European cardiovascular prevention?

The European Society of Cardiology (ESC) has welcomed the publication of the National Institute for Health and Clinical Excellence (NICE) public health guidance on prevention of cardiovascular disease (CVD) at the population level in UK.

read more

June 25, 2010

MADIT-CRT shows women have greater benefit from CRT-D’s

Recently announced results from a sub-analysis of the MADIT-CRT trial data that show that women receive a greater clinical benefit from cardiac resynchronization therapy defibrillators (CRT-Ds) than men. The results were presented during the 17th Cardiostim World Congress by Jonathan Steinberg, M.D., Chief of Cardiology and Director of the Al-Sabah Arrythmia Institute, St. Luke’s-Roosevelt Hospital Center, New York.

read more

June 10, 2010

Contrast-induced nephropathy (CIN) reduced with iodixanol

Results from the largest comparative, randomized clinical trial of patients who are at risk for contrast-induced nephropathy (CIN) demonstrate that VISIPAQUE™ (iodixanol), an iso-osmolar contrast medium, is associated with a significantly lower incidence of CIN in high-risk elderly patients, compared with low-osmolar iopromide, another commonly used contrast medium.

read more

June 10, 2010

Personalized medicine set to impact justice system

Enabled by pharmacogenomics, molecular imaging and other molecular biomarkers, personalized medicine promises to optimize modern medicine and minimize the potential side effects of therapeutic agents. A leading pathologist has now indicated that it may also dramatically impact the justice system, and in ways that we are only just beginning to understand.

read more

May 6, 2010

PCI- safety without surgical cover confirmed

PCI can be performed safely and with significant improvement at centres without a surgical service, according to a study published in the European Journal of Cardiovascular Prevention and Rehabilitation.
There is now little dispute that percutaneous coronary intervention (PCI) has revolutionised the management of patients with acute coronary events such as heart attack. Moreover, improvements in [...]

read more

May 6, 2010

The British Valve Group – a new special interest group

The influence and importance of valve disease is increasing and yet the subject remains under-represented.  There is, for example, no group affiliated to the British Cardiovascular Society and no National Services Framework on valve disease.   A number of interested individuals have recently convened to discuss the formation of a specialist group.
This might issue comments on [...]

read more

Older articles »

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

PROUDLY SPONSORED BY

Sanofi-Aventis Medtronic Sanofi-Aventis Medtronic

ENDORSED BY

  • Arrhythmia Alliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.